These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 56046)

  • 1. Specificity of immune paralysis at large tumor volumes.
    Pardridge DH; Wang BS; Mannick JA; Deckers PJ
    Surg Forum; 1975; 26():118-20. PubMed ID: 56046
    [No Abstract]   [Full Text] [Related]  

  • 2. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage processing of antigen for induction of tumor immunity.
    Brunda MJ; Raffel S
    Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI; Fujimoto S; Sehon AH
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thymus on autosensitization against syngeneic normal and malignant cells.
    Carnaud C; Ilfeld D; Petranyi G; Klein E
    Eur J Immunol; 1975 Aug; 5(8):575-9. PubMed ID: 1234062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased tumour growth after blood transfusion.
    Clarke PJ; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):584-5. PubMed ID: 2705237
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.